Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Loa Loa (eye worm) | pyruvate kinase | 0.0032 | 0.3778 | 0.3778 |
Echinococcus multilocularis | dna polymerase kappa | 0.0037 | 0.4854 | 0.4723 |
Brugia malayi | ImpB/MucB/SamB family protein | 0.0037 | 0.4854 | 0.4854 |
Trypanosoma cruzi | DNA polymerase kappa, putative | 0.0037 | 0.4854 | 0.173 |
Loa Loa (eye worm) | pyruvate kinase | 0.0032 | 0.3778 | 0.3778 |
Loa Loa (eye worm) | hypothetical protein | 0.0026 | 0.243 | 0.243 |
Echinococcus multilocularis | pyruvate kinase | 0.0032 | 0.3778 | 0.362 |
Brugia malayi | latrophilin 2 splice variant baaae | 0.0033 | 0.3922 | 0.3922 |
Loa Loa (eye worm) | hypothetical protein | 0.0026 | 0.2529 | 0.2529 |
Trichomonas vaginalis | DNA polymerase eta, putative | 0.0037 | 0.4854 | 1 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0037 | 0.4854 | 0.3192 |
Trypanosoma brucei | pyruvate kinase 1, putative | 0.0032 | 0.3778 | 0.1768 |
Trypanosoma brucei | DNA polymerase IV, putative | 0.0037 | 0.4854 | 0.3192 |
Loa Loa (eye worm) | intermediate filament protein | 0.0026 | 0.2529 | 0.2529 |
Echinococcus multilocularis | pyruvate kinase | 0.0017 | 0.0519 | 0.0278 |
Echinococcus granulosus | dna polymerase kappa | 0.0037 | 0.4854 | 0.4723 |
Plasmodium vivax | pyruvate kinase, putative | 0.0032 | 0.3778 | 1 |
Schistosoma mansoni | pyruvate kinase | 0.0032 | 0.3778 | 0.362 |
Leishmania major | DNA polymerase eta, putative | 0.0036 | 0.464 | 0.1385 |
Trypanosoma brucei | unspecified product | 0.0037 | 0.4854 | 0.3192 |
Trypanosoma cruzi | DNA polymerase eta, putative | 0.0036 | 0.464 | 0.1385 |
Trypanosoma cruzi | DNA polymerase kappa, putative | 0.0037 | 0.4854 | 0.173 |
Echinococcus multilocularis | pyruvate kinase | 0.0025 | 0.2367 | 0.2173 |
Toxoplasma gondii | ImpB/MucB/SamB family protein | 0.0036 | 0.464 | 1 |
Giardia lamblia | Pyruvate kinase | 0.0032 | 0.3778 | 0.7518 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0037 | 0.4854 | 0.3192 |
Mycobacterium ulcerans | DNA polymerase IV | 0.0037 | 0.4854 | 1 |
Trypanosoma brucei | DNA polymerase IV, putative | 0.0037 | 0.4854 | 0.3192 |
Onchocerca volvulus | Pyruvate kinase homolog | 0.0032 | 0.3778 | 1 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0037 | 0.4854 | 0.3192 |
Chlamydia trachomatis | pyruvate kinase | 0.0032 | 0.3778 | 0.5 |
Mycobacterium tuberculosis | Possible DNA-damage-inducible protein P DinP (DNA polymerase V) (pol IV 2) (DNA nucleotidyltransferase (DNA-directed)) | 0.0037 | 0.4854 | 1 |
Brugia malayi | calcium-independent alpha-latrotoxin receptor 2, putative | 0.0015 | 0.0248 | 0.0248 |
Schistosoma mansoni | hypothetical protein | 0.0033 | 0.3922 | 0.3768 |
Echinococcus granulosus | pyruvate kinase | 0.0017 | 0.0519 | 0.0278 |
Schistosoma mansoni | DNA polymerase eta | 0.0062 | 1 | 1 |
Brugia malayi | Pyruvate kinase, muscle isozyme | 0.0032 | 0.3778 | 0.3778 |
Brugia malayi | Intermediate filament tail domain containing protein | 0.0026 | 0.2529 | 0.2529 |
Trypanosoma brucei | DNA polymerase eta, putative | 0.0062 | 1 | 1 |
Trypanosoma cruzi | DNA polymerase kappa, putative | 0.0037 | 0.4854 | 0.173 |
Loa Loa (eye worm) | hypothetical protein | 0.0033 | 0.3922 | 0.3922 |
Trypanosoma cruzi | DNA polymerase eta, putative | 0.0062 | 1 | 1 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0037 | 0.4854 | 0.3192 |
Echinococcus granulosus | lamin dm0 | 0.0026 | 0.2529 | 0.2339 |
Schistosoma mansoni | pyruvate kinase | 0.0017 | 0.0519 | 0.0278 |
Brugia malayi | Corticotropin releasing factor receptor 2 precursor, putative | 0.0048 | 0.7089 | 0.7089 |
Loa Loa (eye worm) | latrophilin receptor protein 2 | 0.0015 | 0.0248 | 0.0248 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0037 | 0.4854 | 0.3192 |
Trypanosoma cruzi | DNA polymerase kappa, putative | 0.0037 | 0.4854 | 0.173 |
Onchocerca volvulus | Pyruvate kinase homolog | 0.0032 | 0.3778 | 1 |
Mycobacterium tuberculosis | Conserved hypothetical protein | 0.0037 | 0.4854 | 1 |
Echinococcus granulosus | intermediate filament protein | 0.0026 | 0.2529 | 0.2339 |
Echinococcus multilocularis | terminal deoxycytidyl transferase rev1 | 0.0037 | 0.4854 | 0.4723 |
Echinococcus multilocularis | lamin | 0.0026 | 0.2529 | 0.2339 |
Trypanosoma brucei | pyruvate kinase 1 | 0.0032 | 0.3778 | 0.1768 |
Schistosoma mansoni | rab geranylgeranyl transferase alpha subunit | 0.0037 | 0.4854 | 0.4723 |
Echinococcus granulosus | terminal deoxycytidyl transferase rev1 | 0.0037 | 0.4854 | 0.4723 |
Brugia malayi | Pyruvate kinase, M2 isozyme | 0.0032 | 0.3778 | 0.3778 |
Schistosoma mansoni | terminal deoxycytidyl transferase | 0.0037 | 0.4854 | 0.4723 |
Loa Loa (eye worm) | hypothetical protein | 0.0062 | 1 | 1 |
Echinococcus multilocularis | lamin dm0 | 0.0026 | 0.2529 | 0.2339 |
Plasmodium falciparum | pyruvate kinase | 0.0032 | 0.3778 | 1 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0037 | 0.4854 | 0.3192 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0037 | 0.4854 | 0.3192 |
Giardia lamblia | DINP protein human, muc B family | 0.0037 | 0.4854 | 1 |
Leishmania major | DNA polymerase kappa, putative | 0.0037 | 0.4854 | 0.173 |
Entamoeba histolytica | deoxycytidyl transferase, putative | 0.0037 | 0.4854 | 1 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0037 | 0.4854 | 0.3192 |
Mycobacterium leprae | Probable pyruvate kinase PykA | 0.0032 | 0.3778 | 0.5 |
Onchocerca volvulus | Pyruvate kinase homolog | 0.0032 | 0.3778 | 1 |
Trypanosoma brucei | DNA polymerase IV, putative | 0.0037 | 0.4854 | 0.3192 |
Echinococcus granulosus | pyruvate kinase | 0.0032 | 0.3778 | 0.362 |
Loa Loa (eye worm) | hypothetical protein | 0.0015 | 0.0248 | 0.0248 |
Schistosoma mansoni | intermediate filament proteins | 0.0026 | 0.2529 | 0.2339 |
Echinococcus multilocularis | pyruvate kinase | 0.0017 | 0.0519 | 0.0278 |
Echinococcus multilocularis | pyruvate kinase | 0.0017 | 0.0519 | 0.0278 |
Loa Loa (eye worm) | hypothetical protein | 0.0022 | 0.1752 | 0.1752 |
Echinococcus granulosus | lamin | 0.0026 | 0.2529 | 0.2339 |
Echinococcus granulosus | pyruvate kinase | 0.0032 | 0.3778 | 0.362 |
Brugia malayi | Latrophilin receptor protein 2 | 0.0015 | 0.0248 | 0.0248 |
Loa Loa (eye worm) | ImpB/MucB/SamB family protein | 0.0037 | 0.4854 | 0.4854 |
Leishmania major | DNA polymerase kappa, putative,DNA polymerase IV, putative | 0.0037 | 0.4854 | 0.173 |
Loa Loa (eye worm) | hypothetical protein | 0.0048 | 0.7089 | 0.7089 |
Echinococcus granulosus | dna polymerase eta | 0.0062 | 1 | 1 |
Echinococcus multilocularis | dna polymerase eta | 0.0062 | 1 | 1 |
Leishmania major | DNA polymerase eta, putative | 0.0062 | 1 | 1 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.0048 | 0.7089 | 0.7089 |
Echinococcus multilocularis | pyruvate kinase | 0.0032 | 0.3778 | 0.362 |
Schistosoma mansoni | pyruvate kinase | 0.0032 | 0.3778 | 0.362 |
Loa Loa (eye worm) | pyruvate kinase-PB | 0.0022 | 0.1752 | 0.1752 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0037 | 0.4854 | 0.3192 |
Trichomonas vaginalis | DNA polymerase IV / kappa, putative | 0.0037 | 0.4854 | 1 |
Echinococcus granulosus | pyruvate kinase | 0.0017 | 0.0519 | 0.0278 |
Brugia malayi | intermediate filament protein | 0.0026 | 0.2529 | 0.2529 |
Toxoplasma gondii | pyruvate kinase PyK1 | 0.0032 | 0.3778 | 0.7908 |
Echinococcus multilocularis | musashi | 0.0026 | 0.2529 | 0.2339 |
Echinococcus granulosus | pyruvate kinase | 0.0017 | 0.0519 | 0.0278 |
Loa Loa (eye worm) | pyruvate kinase | 0.0032 | 0.3778 | 0.3778 |
Loa Loa (eye worm) | hypothetical protein | 0.0032 | 0.3778 | 0.3778 |
Mycobacterium ulcerans | DNA polymerase IV | 0.0037 | 0.4854 | 1 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.0048 | 0.7089 | 0.7089 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0037 | 0.4854 | 0.3192 |
Schistosoma mansoni | lamin | 0.0026 | 0.2529 | 0.2339 |
Loa Loa (eye worm) | intermediate filament tail domain-containing protein | 0.0026 | 0.2529 | 0.2529 |
Schistosoma mansoni | lamin | 0.0026 | 0.2529 | 0.2339 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.